Modern weight-loss medications, especially those that target GLP-1 receptors like Wegovy and Ozempic, have sparked considerable debate regarding their safety, particularly following reports of pancreatitis in some users.
But how real are these risks? And should we be concerned?
Ozempic Benefits
What is pancreatitis and why is it dangerous?
Pancreatitis is a medical condition characterized by swelling and inflammation of the pancreas. It can be acute or chronic and leads to symptoms such as:
Severe abdominal pain, nausea, and vomiting.
Elevated pancreatic enzymes in the blood.
In severe cases, it can cause serious complications.
Do GLP-1 medications increase the risk of pancreatitis?
Experts point out that there are isolated reports of pancreatitis in users of GLP-1 medications, but large-scale studies have not demonstrated a significant increase in risk.
According to a comprehensive scientific review, no significant difference was found in the rate of pancreatitis between users of these medications and non-users, although rare cases have been reported. Regulators also recommend monitoring for symptoms and discontinuing the medication if pancreatitis is suspected.
What do official health bodies say?
The U.S. Food and Drug Administration (FDA) warns that pancreatitis may be a rare side effect of some GLP-1 drugs, but emphasizes that a causal relationship is not fully established, and that the benefits of these drugs in treating diabetes and obesity outweigh the risks for most patients.
Who is most at risk?
Doctors indicate that some people may be more at risk, such as:
Those with a history of pancreatitis.
Those with gallstones.
Those who drink heavily.
Those with high triglycerides.
A quick way to detect pancreatic cancer before it's too late - Imago
There are isolated reports of pancreatitis in users of GLP-1 drugs (Deutsche Welle).
Symptoms to watch out for
Experts recommend stopping the medication and consulting a doctor immediately if:
Severe and persistent pain in the upper abdomen.
Frequent vomiting. Pain that radiates to the back.
Should these medications be discontinued?
Experts confirm that GLP-1 medications are among the most effective obesity treatments currently available, and they should not be stopped without consulting a doctor, especially since most users do not experience serious side effects. However, individual assessment of each patient remains essential.